ERBB2 and breast cancer: Subsequent examination of METTL1 and WDR4 mRNA transcripts in different BC subtypes revealed slightly lower relative levels in HER2-positive or triple-negative subtypes compared to luminal A and B subtypes, as well as normal breast tissues (Fig. 1D-E).